These findings reveal an additional function of Sin1–mTORC2 in the immune-metabolic regulation of thymocyte DN3–DN4 transition, and may provide new strategies and potential targets for the clinical treatment of T cell lymphopenia or T cell lymphoma. The gene discussed is MAPKAP1; the disease is T-cell non-Hodgkin lymphoma.